Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease-Reference-Cited by-同舟云学术

Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease

Published:2024-01 Issue:1 Volume:22 Page:152-162
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Verhagen Marieke J.A.,van Balen Erna C.,Blijlevens Nicole M.A.,Coppens Michiel,van Heerde Waander L.,Leebeek Frank W.G.,Rijpma Sanna R.,van Vulpen Lize F.D.,Gouw Samantha C.,Schols Saskia E.M.

Publisher

Elsevier BV

Subject

Hematology

Reference26 articles.

1. WFH Guidelines for the Management of Hemophilia, 3rd edition;Srivastava;Haemophilia,2020

2. The phenotypic heterogeneity of severe hemophilia;Jayandharan;Semin Thromb Hemost,2008

3. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B;Ahlberg;Acta Orthop Scand Suppl,1965

4. Outcome in moderate haemophilia;den Uijl;Blood Transfus,2014

5. Clinical outcome of moderate haemophilia compared with severe and mild haemophilia;den Uijl;Haemophilia,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology;Journal of Thrombosis and Haemostasis;2024-09

2. Joint health and pain in the changing hemophilia treatment landscape;Expert Review of Hematology;2024-07-15

3. Clinical Efficacy of Intra‐articular Tranexamic Acid Injection in the Management of Hemophilia with Total Hip Arthroplasty: A 24‐month Retrospective Cohort Study;Orthopaedic Surgery;2024-06-03

4. Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis;Orphanet Journal of Rare Diseases;2024-03-26